HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Curcumin Touted For Oral Health Gets EFSA Novel Food Nod

Executive Summary

In its latest batch of novel food assessments, the European Food Safety Authority gave the nod to a curcumin supplement touted for its oral health benefits, but rejected applications for flowering plant Tongkat Ali and water lentil Wolffia globosa.

You may also be interested in...



Iron Supplement Claiming To Preserve Gut Microbiome Gets EU Novel Food Nod

A dietary supplement claimed to treat iron deficiency without negatively impacting the gut microbiome has secured a positive opinion as a novel food from the European Food Safety Authority.

‘Beneficial Bacteria’ Gets Novel Food Approval From EFSA

EFSA has given a positive opinion on the safety of Akkermansia muciniphila as a novel food. Naturally occurring in the human gut, A. muciniphila can help to control fat storage and glucose metabolism, claims applicant A-Mansia.

GSK Rejects £50bn Bid For Consumer Healthcare From Unilever

GSK says London-based Unilever's £50bn bid for Consumer Healthcare fundamentally undervalues a business which generated sales close to £10bn last year and is expected to grow 4-6% over the medium term. The rejection has not dissuaded Unilever, however, with the company intent on stepping up its presence in the health, beauty and hygiene categories.

Topics

UsernamePublicRestriction

Register

RS152087

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel